Perspectives

Just as it was impossible for previous generations to predict today’s scientific and technological advances, we are similarly challenged when looking to the future. But the path to progress begins with innovation.

In the 21st century, it is anticipated that vaccines will play an equally significant role, addressing issues that include increased life expectancy, emerging infections and childhood mortality in developing countries.

Dr. Ronald Sokol’s life work revolves around the research and treatment of childhood liver diseases and other pediatric disorders.

This safety-themed edition of BioSupply Trends Quarterly addresses this patient safety and how it can be improved.

Mark Harris, PhD, is the founder and chief executive officer of NextGxDx, a healthcare information company that provides a web-based genetic diagnostics marketplace.

In this plasma-themed issue of BioSupplyTrends Quarterly, we take a critical look at each of these segments of the plasma market.

Kedrion President and CEO Paolo Marcucci discusses Kedrion's goal to strengthen its role as strategic partner of national health systems.

In this issue, we explore novel technologies shaping the future of the healthcare landscape.

As we celebrate our third year in publication, we begin by exploring innovations in vaccine research and technology.

Brent MacGregor, president of Novartis Vaccines, U.S., plans to build upon the current Novartis Vaccines culture, which he says promotes an entrepreneurial spirit coupled with an element of risk-taking that he thrives on.

With a global presence in more than90 countries, Grifols had long established itself as a standard-bearer within the plasma therapies industry.

With the number of counterfeit drug investigations having grown almost tenfold in the last five years, the number of prescription drug shortages nearly tripling from 2005 to 2010, and with recent indications that this threat is increasing rather than diminishing, keeping patients safe has never been more challenging.